Abdominal fat-related activation of the innate immune system and insulin resistance (IR) are implicated in the pathogenesis of cardiovascular diseases. Recent data support an important role of the adaptive immune system as well. In this study, we investigate the association between waist circumference and markers of systemic adaptive immune activation, and the potential mediating role of innate immune activation and/or IR herein. The study population consisted of 477 (304 men) individuals (mean age: 59.4±7.0 years) in whom waist circumference, HOMA2-IR (IR derived from homeostasis model assessment), and markers of innate (C-reactive protein (CRP), interleukin (IL)-6, serum amyloid A (SAA)) and adaptive (neopterin, soluble CD25 (sCD25)) immune activation were measured. These markers were compiled into an adaptive and innate immune activation score by averaging the respective z-scores. After adjustments for age, sex, glucose metabolism, smoking status, prior cardiovascular disease, and other risk factors, waist circumference was associated with the adaptive (standardized regression coefficient Β = 0.12 (95% confidence intervals: 0.04-0.20)) and the innate immune activation scores (Β = 0.24 (0.17-0.31)), and with HOMA2-IR (Β = 0.49 (0.42-0.56)). The innate immune activation score and HOMA2-IR were also positively associated with the adaptive immune activation score (Β = 0.31 (0.21-0.40) and Β = 0.11 (0.02-0.21), respectively). The association between waist circumference and the adaptive immune activation score was completely abolished when further adjusted for innate immune activation and HOMA2-IR (to Β = 0.01 (0.10-0.08)), and the specific mediation effects attributable to each of these variables were 58% and 42%, respectively. We conclude that abdominal obesity is associated with systemic adaptive immune activation and that innate immune activation and IR constitute independent and equally important pathways explaining this association.
articles nature publishing group epidemiology IntroductIon Obesity, in particular abdominal obesity, increases the risk of several chronic diseases such as hypertension, diabetes, and cardiovascular diseases (1) . Although the underlying pathophysiological mechanisms explaining these associations have not been completely unraveled, chronic low-grade inflammation and insulin resistance (IR), which are intertwined, are thought to play a key role in these (abdominal) obesity-related complications (2) (3) (4) (5) .
Inflammation associated with excessive abdominal fat mass starts locally in the adipose tissue (6) . With increasing obesity, proinflammatory macrophages accumulate in adipose tissue (7) . Adipose tissue macrophages are responsible for almost all adipose tissue tumor necrosis factor-α and contribute significantly to adipose tissue-derived interleukin-6 (IL-6) (7), molecules involved in systemic IR (8, 9) . Although research so far has focused mainly on innate immune mechanisms and markers of obesity-related inflammation, recent observations have drawn some attention to the role of adaptive immune mechanisms in obesity and related sequelae. Indeed, accumulation of adaptive immune cells, such as T cells, has been demonstrated in adipose tissue in obesity (10, 11 Abdominal fat-related activation of the innate immune system and insulin resistance (IR) are implicated in the pathogenesis of cardiovascular diseases. Recent data support an important role of the adaptive immune system as well. In this study, we investigate the association between waist circumference and markers of systemic adaptive immune activation, and the potential mediating role of innate immune activation and/or IR herein. The study population consisted of 477 (304 men) individuals (mean age: 59.4 ± 7.0 years) in whom waist circumference, HOMA2-IR (IR derived from homeostasis model assessment), and markers of innate (C-reactive protein (CRP), interleukin (IL)-6, serum amyloid A (SAA)) and adaptive (neopterin, soluble CD25 (sCD25)) immune activation were measured. These markers were compiled into an adaptive and innate immune activation score by averaging the respective z-scores. After adjustments for age, sex, glucose metabolism, smoking status, prior cardiovascular disease, and other risk factors, waist circumference was associated with the adaptive (standardized regression coefficient β = 0.12 (95% confidence intervals: 0.04-0.20)) and the innate immune activation scores (β = 0.24 (0.17-0.31)), and with HOMA2-IR (β = 0.49 (0.42-0.56)). The innate immune activation score and HOMA2-IR were also positively associated with the adaptive immune activation score (β = 0.31 (0.21-0.40) and β = 0.11 (0.02-0.21), respectively). The association between waist circumference and the adaptive immune activation score was completely abolished when further adjusted for innate immune activation and HOMA2-IR (to β = −0.01 (−0.10-0.08)), and the specific mediation "effects" attributable to each of these variables were 58% and 42%, respectively. We conclude that abdominal obesity is associated with systemic adaptive immune activation and that innate immune activation and IR constitute independent and equally important pathways explaining this association.
articles epidemiology studies suggest that T lymphocytes are crucially involved in the initiation and maintenance of adipose tissue inflammation and systemic IR (11) (12) (13) (14) . It should be noted that most of these data were obtained in mouse models of obesity and focused on the local inflammatory process in adipose tissue. However, the extent to which these mechanisms translate to humans and are operable at the systemic level is largely unknown. To that aim, investigating associations of (central) obesity with markers discerning between the innate and adaptive immune activation, as well as the role of IR herein, may thus enable a better understanding of these mechanisms. Macrophages are a major source of circulating IL-6 (7), which induces hepatic production of acute phase reactants such as C-reactive protein (CRP) and serum amyloid A (SAA). The levels of these molecules are commonly used as markers of activation of the innate immune system (15) . On the other hand, levels of soluble CD25 (sCD25) and neopterin can be considered as markers of adaptive immune activation. Production of the soluble IL-2 receptor (sCD25) is associated with T-cell activation in vitro (16, 17) . In addition, increased serum sCD25 levels have been associated with lymphocyte activation in infection, autoimmune diseases and hematologic malignancies (18) (19) (20) . Neopterin, a product of interferon-γ-activated monocytes/ macrophages is a sensitive indicator of cell-mediated immune activation. In humans, increased concentrations of neopterin in serum and urine have been found during allograft rejection episodes and in various malignant disorders, autoimmune diseases, and viral infections (21) . In view of these considerations, we have examined, in a large cohort of individuals at increased risk of diabetes and cardiovascular disease: (i) whether waist circumference, a surrogate marker of abdominal fat mass (22) , is associated with adaptive immune activation, as characterized by elevations in neopterin and sCD25, and (ii) the extent to which any such associations are explained, i.e., are potentially mediated, by innate immune activation and/or IR.
Methods and Procedures subjects and study design
We used data from the Cohort of Diabetes and Atherosclerosis Maastricht Study, an ongoing prospective cohort study in the Netherlands that was originally designed to study the effects of obesity, glucose tolerance, lipid metabolism, lifestyle and genetics on cardiovascular complications, and that has been described in detail elsewhere (23, 24) . Briefly, between 1999 and 2001 subjects were selected from a large population-based cohort and included if they had white ethnicity and were older than 40 years and one or more of the following criteria: BMI >25 kg/m 2 , positive family history for type 2 diabetes mellitus, history of gestational diabetes, postprandial blood glucose >6.0 mmol/l, glucosuria, or use of antihypertensive medication. In total, 574 subjects were included and were extensively characterized with regard to their metabolic, cardiovascular, and lifestyle risk profiles during two visits to the University's research unit. For the present study, we excluded subjects with missing data on markers of adaptive and/or innate immune activation, IR and/or important covariates (n = 87) and those on insulin treatment (n = 10), and thus the total study population consisted of 477 individuals. Subjects excluded (n = 97) did not differ from those included with regard to levels of waist circumference and other cardiovascular risk factors (data not shown).
All subjects gave written informed consent and the study was approved by the medical ethical committee of the Maastricht University Medical Centre.
anthropometrics Height (in cm) was measured with subjects standing upright against a stadiometer. Body weight was measured to the nearest 100 g on electronic weight scales. BMI was calculated by dividing weight by height squared and expressed in kg/m 2 . Waist circumference was measured with a flexible tape at the level midway between the lowest rib and the iliac crest.
Ir and markers of innate immune activation
Subjects were asked to stop their lipid-lowering medication 14 days prior to the blood withdrawals and to refrain from eating and drinking after 10:00 pm in the evening before. After an overnight fast (duration of at least 10 h), subjects underwent a standard 75-g oral glucose tolerance test with venous blood sampling. Fasting plasma glucose and postload glucose levels were measured with a glucose hexokinase-6 method (ABX Diagnostics, Montpellier, France). Subjects' glucose metabolism status (i.e., normal, impaired or type 2 diabetes) was defined according to the World Health Organization's criteria of 1999 (25) . IR was derived from the homeostasis model assessment (HOMA2-IR) with the use of software downloaded at http://www.dtu.ox.ac.uk.
High sensitivity CRP was measured in serum with a high sensitivity kit (Latex; Roche Diagnostics Netherlands, Almere, the Netherlands). IL-6 was measured in EDTA plasma with a high sensitivity human Quantikine enzyme-linked immunosorbent assay kit (R&D systems, Minneapolis, MN). SAA was measured in EDTA plasma using a human invitrogen enzyme-linked immunosorbent assay kit (Biosource International, Camarillo, CA).
Markers of adaptive immune activation
Neopterin was measured using a commercially available competitive enzyme-linked immunosorbent assay (IBL, Hamburg, Germany), according to the manufacturer's instructions. sCD25 was measured by a sandwich enzyme-linked immunosorbent assay using a commercially available antibody pair obtained from Diaclone (Diaclone Research, Besancon, France). Both markers were measured in serum samples. Both intra-assays coefficients of variation were <10%.
other risk factors Glycated hemoglobin (HbA 1c ) was determined by ion-exchange highperformance liquid chromatography (HPLC; Bio-Rad, Veenendaal, the Netherlands). Total and high-density lipoprotein cholesterol and triglycerides were measured in EDTA plasma by enzymatic methods (Roche, Mannheim, Germany), and low-density lipoprotein cholesterol was calculated according to the Friedwald formula.
Systolic and diastolic blood pressure were measured twice on each visit, and the mean values were used in the analyses; readings were taken on the right arm, with subjects in the supine position after they had rested for 5 min, with the use of an oscillometric device (Maxi stable 3; Speidel & Keller, currently: Welch Allyn, Skaneateles Falls, NY). Pulse pressure was calculated as systolic blood pressure−diastolic blood pressure, mean arterial pressure as diastolic blood pressure+1/3 pulse pressure and hypertension was defined as systolic blood pressure/diastolic blood pressure ≥140/90 and/or the use of antihypertensive medication (26) .
Smoking behavior was assessed by means of questionnaires and subjects were categorized into never, ex-and current smokers. Use of blood pressure-, glucose-or lipid-lowering medication was also assessed by questionnaire. Prior cardiovascular disease was defined as the occurrence of myocardial infarction, bypass of the coronary arteries, percutaneous coronary intervention, stroke, or nontraumatic limb amputation (ascertained by questionnaire), and/or the presence of signs of myocardial infarction (i.e., Minnesota codes 1-1 or 1-2) or ischemia (i.e., Minnesota codes 1-3, 4-1, 4-2, 4-3, 5-1, 5-2, 5-3 or 7-1) on a 12-lead electrocardiography, and/or an ankle-brachial index <0.9 in either leg. Variables with a skewed distribution (i.e., triacylglycerol, insulin, HOMA2-IR, CRP, IL-6, SAA and sCD25) were log 10 -transformed prior to further analyses. ANOVA or χ 2 tests were used, as appropriate, to compare subjects' characteristics across tertiles of waist circumference. We computed a continuous "adaptive immune activation score" by averaging the z-scores (i.e., (subject's value−group's mean)/group's s.d.) of neopterin and log 10 sCD25, and an "innate immune activation score" by averaging the z-scores of log 10 CRP, log 10 IL-6, and log 10 SAA. These scores enable a more robust characterization of the mechanisms represented and help overcome the problem of misclassification, the latter often leading to an underestimation of the strength of the associations when each marker is analyzed separately.
Simple and multiple mediation analyses. When simple and/ or multiple mediation hypotheses are entertained, as in the present study, the magnitude of the associations linking all the variables of interest need to be established first (27) . We have therefore used multiple linear regression analyses to ascertain: (i) the association between waist circumference (X) and the adaptive immune activation score (Y)-path c; (ii) the association between X and each of the mediators (M(s)) proposed, i.e., innate immune activation score and IR-path(s) a; and (iii) the association between the M(s) and Y, when controlling for X and the other mediator in multiple mediation models-path(s) b. Path c thus represents the total "effect" of X on Y, which can be apportioned into the direct "effects" of X on Y (path c′) + the indirect effect of X on Y through the M(s) (paths ab or c-c′)- Figure 1a ,b, for simple mediation and Figure 1a ,c for multiple mediation models (28) (29) (30) . All these analyses were performed with adjustments for the following covariates: age, sex, glucose metabolism status, smoking status and prior cardiovascular disease, and also for other risk factors, i.e., HbA 1c , mean arterial pressure, total-to-high-density lipoprotein cholesterol ratio and triacylglycerol. Results hereby obtained were reported as standardized regression coefficients (β) and respective 95% confidence intervals to enable comparison of the strength of the associations investigated. Traditionally, mediation is considered to be present when the strength of the association between X and Y (path c) decreases by a nontrivial amount after further adjustment for the M(s)-path c′; the ratio of the indirect to the total "effects" (i.e., ab/c) is then often interpreted as the proportion of the total effect that is mediated by the mediator(s) (27, 28) . However, and according to recent recommendations regarding mediation data analyses procedures, this concept is flawed in situations when c < ac (yielding proportion >1), c and ab have different directions (yielding negative proportions), c = 0 (yielding a situation in which the proportion is undefined) or when c is close to 0 (when any trivial mediation may seem massive) (28, 31) . Instead, a better approach is to estimate the magnitude of the indirect "effect(s)" and the respective 95% confidence intervals, thereby enabling the testing of whether such "effects" differ significantly from 0 (29). In addition, when multiple mediators are investigated, as in the present case, contrasting the specific indirect "effects" attributable to one vs. the other mediator is of interest (30) . Accordingly, we computed bootstrapped (bias-corrected) confidence intervals (5,000 samples) for the size of the specific mediation "effects" using SPSS macros provided by Preacher & Hayes (30) . These analyses enabled the appreciation of whether any of the proposed mediators exerts a predominant role in the association investigated, thus contributing to a better understanding of the operative pathophysiological mechanisms (28, 30, 31) . Table 1 shows the general characteristics of the study population across tertiles of waist circumference. Subjects with increasing levels of waist circumference were characterized by a more adverse cardiovascular risk profile. Levels of markers of adaptive and innate immune activation and their scores, as well as HOMA2-IR, were also significantly increased across tertiles of waist circumference. The innate immune activation score (and each of its constituent markers) were positively and significantly associated with articles epidemiology neopterin, sCD25, and the adaptive immune activation score ( Table 3) . These associations were independent of age, sex, glucose metabolism, smoking status, prior cardiovascular disease (model 1), other risk factors (model 2), but also of waist circumference (model 3) and HOMA2-IR (model 4a): β = 0.31 (0.21 to 0.40), P < 0.001, for the association between the innate and the adaptive immune activation scores. After all adjustments (model 4b), HOMA2-IR was also positively and significantly associated with the adaptive immune activation score: β = 0.11 (0.02 to 0.21), P = 0.021.
Mediating role of innate immune activation and/or Ir in the association between waist circumference and adaptive immune activation
The strength of the association between waist circumference and the adaptive immune activation score (β = 0.118 (0.038 to 0.197)) was attenuated and no longer significant when further adjusted for innate immune activation score (to β = 0.038 (−0.041 to 0.118), P = 0.346) or HOMA2-IR (to β = 0.048 (−0.044 to 0.141), P = 0.304), respectively ( Table 4 ). The indirect associations of waist circumference on adaptive immune activation score through the innate immune activation score or through HOMA2-IR were both significant: β = 0.079 (0.050 to 0.117), P < 0.001 and β = 0.069 (0.021 to 0.128), P = 0.011, respectively-simple mediation analyses. When adjustments for both mediators were considered simultaneously, the association between waist circumference and the adaptive immune activation score was completely abolished to β = −0.013 (−0.104 to 0.077), P = 0.777, and thus the total indirect associations through the mediators had a magnitude of 0.131 (0.077 to 0.192), P < 0.001. Analyses performed in order to tease apart the specific relative contribution of the immune activation score and of HOMA2-IR as mediators of this association showed that these had a magnitude of β = 0.076 (0.048 to 0.115), P < 0.001 and β = 0.054 (0.006 to 0.111), P = 0.041, or 58% vs. 42%, respectively, which were not statistically different from each other, however (β = −0.022 (−0.087 to 0.043), P = 0.508).
additional analyses
We also conducted analyses with BMI, instead of waist circumference, as main determinant of adaptive immune activation. All associations, including the mediation role of innate immune activation and HOMA2-IR, were very similar to those reported herein (data not shown). low-density lipoprotein-lowering drugs including statins have been demonstrated to exert immunosuppressive activities (reviewed in ref. 32 ). However, none of the associations described herein changed materially after further adjustments for the use of lipid-lowering medication (data not shown). Replacing mean arterial pressure by systolic blood pressure or hypertension as a covariate in our models also did not change any of the estimates reported (data not shown).
dIscussIon
The main findings of the present study are threefold. First, waist circumference, a marker of abdominal fat mass, is associated not only with higher systemic levels of markers of innate immune activation and IR but also with higher levels of markers of adaptive immune activation. Second, the association between abdominal fat and adaptive immune activation is completely explained, i.e., mediated, by abdominal fat-related elevations in innate immune activation and IR. Finally, each of these mediators represents independent pathways of similar importance linking abdominal fat to adaptive immune activation. Using a flow-cytometric approach, adaptive immune activation has recently been demonstrated in morbidly obese study articles epidemiology subjects (33) . Positive associations between measures of (central) obesity and neopterin have previously been shown in a large cohort of apparently healthy individuals (34) and two small studies on healthy and obese individuals (35, 36) . We have now confirmed but also extended those findings to yet another marker of adaptive immune activation-sCD25-in a relatively large cohort of individuals at increased risk of type 2 diabetes and cardiovascular disease. In addition, this is the first study that has investigated not only the association between abdominal fat and markers of adaptive immune activation, but also potential underlying mechanisms explaining any such associations. Recent papers suggest that T lymphocytes are critically involved in the regulation of adipose tissue inflammation. Nishimura and colleagues showed that adipose tissue CD8 + T cells have an essential role in macrophage recruitment (12) . CD4 + effector cells can generally be divided into proinflammatory cells (T helper (Th)1, Th17), and anti-inflammatory cells and regulatory sublineages (Th2, Tregs). In adipose tissue in lean mice, Th2 and Treg cells predominate and these cells seem to be critically involved in the regulation of body weight, adipose tissue inflammation and IR (13, 14) . In both human and mice, there is a shift in adipose tissue T-cell populations so that CD8 + and Th1 T cells dominate (13) . Th1-derived interferon-γ is classically known to activate macrophages. This process may augment proinflammatory cytokine (like IL-1β, tumor necrosis factor-α, and IL-6) production in the adipose tissue and these molecules may then be released into the systemic circulation. Indeed, the present study confirms that serum levels of tumor necrosis factor-α, IL-6, and acute phase reactants such as CRP and SAA are higher in individuals with greater levels of (central) obesity (15) .
The involvement of innate and adaptive immune components in the inflammatory process at the local level (i.e., in adipose tissue) may differ from that at the systemic circulation level. In adipose tissue, adaptive immune cells (T cells) appear to initiate and regulate innate immune cells and hereby IR, whereas in the systemic circulation the adaptive immune articles epidemiology system may get involved as a result of adipose-related increases in innate immune activation and/or IR. Our data are consistent with this hypothesis which can find some support from the following observations. Proinflammatory cytokines, derived from innate immune cells, may lower the threshold for peripheral T-cell activation (37) . In addition, maturation, and consequently the ability of antigen-presenting cells to elicit a T-cell response, may be enhanced in an inflammatory microenvironment (38) . Nevertheless, T-cell activation is critically dependent on specific triggering of the T-cell receptor. The triggers for the observed obesity-associated systemic T-cell activation remain speculative although there is abundant expression of candidate T-cell-triggering antigens in obese subjects. IR was the other important mediator in the observed association between abdominal fat and adaptive immune activation. Besides the regulation of glucose and lipid metabolism, a number of other biological functions have been assigned to insulin, including an anti-inflammatory function. (39) . The inability of T cells to respond to insulin, e.g., T-cell IR, might result in a more Th1-polarized T-cell compartment. Since neopterin is a product of interferon-γ-activated macrophages, the higher neopterin levels in subjects in the highest tertile of waist circumference suggest that the Th1 T-cell compartment in these subjects is in a more activated state. The low level of insulin sensitivity in this group of subjects might have contributed to this.
The role of the adaptive immune system in the pathogenesis of obesity-related vascular complications remains speculative. Guzik et al. showed that T cells and T-cell-derived tumor necrosis factor-α and IL-17 are involved in the pathogenesis of hypertension (40, 41) . In addition, subsets of T cells have been demonstrated to play critical roles in atherogenesis (reviewed in ref. 42 ). The presence of activated T cells in articles epidemiology atheromatous lesions implies that these cells are involved in a specific immune reaction, probably directed against locally expressed or formed (auto)antigens, e.g., oxidized low-density lipoprotein (43) . T lymphocytes can influence atherogenesis progression by regulating the magnitude of the inflammatory response within the plaque, as well as plaque stability and the propensity for thrombus formation. Further research in this area is nevertheless needed.
Limitations of the present study have to be taken into account. First, the separation of markers into markers of innate or adaptive immune activation is not absolute. IL-6 can also be made by T cells, but macrophages and adipocytes are primary sources. In addition, sCD25 is predominantly released from activated T cells, although it may also be released from activated B cells and natural killer cells. Upon activation, Th1 cells secrete large amounts of interferon-γ, which will subsequently trigger neopterin release from monocytes (44) . Although monocytes belong to the innate immune system, neopterin is not released in the absence of T-cell activation. Consequently, neopterin is considered to be a marker of adaptive immune cell activation. Second, our research questions were addressed within the context of a cross-sectional study design, which hinders definite conclusion in terms of causality. Indeed, although we hypothesized and tested "causal models" linking abdominal fat to (markers of) adaptive immune activation through abdominal fat-related increases in innate immune activation and/or IR pathways, we cannot discard the possibility of reverse causation. In other words, associations between abdominal fat and innate inflammation and/or IR could (also) be explained, i.e., mediated, by abdominal fat-related increases in adaptive immune activation. Indeed, additional analyses testing these reverse causation models also showed that these pathways could be operative, but with much smaller mediating magnitudes (13 and 3%, respectively) than the ones reported under our primary hypothesis (data not shown). Longitudinal and time-lagged data are thus needed to further investigate the directions of the associations tested. Finally, our study population consisted of middle-aged and older white individuals at high risk for type 2 diabetes and cardiovascular disease. Caution is thus needed in the extrapolation of our findings to other populations (i.e., younger and/or healthier and of other ethnicities).
In conclusion, on the basis of multiple mediation analyses, our data suggest that the associations between abdominal obesity and adaptive immune activation could be due to obesity-related innate immune activation and IR. Further research is needed to gain more insight into the triggers of the observed abdominal fat-related T-cell activation and to elucidate the role of the adaptive immune system, and more specifically of T cells, in the pathogenesis of obesity-related vascular complications.
